ATIC ATIC | Accelerating immunotherapy treatment for T1D.

Breaking News!  The SAFEGUARD trial is now seeking children and teens (aged 5-17) who are newly diagnosed with type 1 di...
03/09/2026

Breaking News! The SAFEGUARD trial is now seeking children and teens (aged 5-17) who are newly diagnosed with type 1 diabetes to participate in a clinical trial that aims to protect the body's ability to make insulin!
We have clinical trial sites across Australia and New Zealand.
More information is available on our website: atic.svi.edu.au/clinical-trials or you can contact our friendly team via email [email protected]

Remember our BANDIT study? 💙BANDIT showed that baricitinib, an immunotherapy drug, could help protect the insulin-produc...
31/08/2026

Remember our BANDIT study? 💙
BANDIT showed that baricitinib, an immunotherapy drug, could help protect the insulin-producing beta cells in people recently diagnosed with type 1 diabetes. People who took baricitinib for 48 weeks were able to keep producing more of their own insulin and needed less injected insulin than those who received placebo. This new follow-up study asked an important question: what happens after treatment stops?
You can read more here:

Further results from the BANDIT study have been published in Diabetes Care.

Are you an adult living with type 1 diabetes who is interested in taking part in the research of a new treatment?  The M...
25/08/2026

Are you an adult living with type 1 diabetes who is interested in taking part in the research of a new treatment?
The MT101-101 study is now available in Melbourne, Brisbane and the Gold Coast. There are more details available on the ATIC website (atic.svi.edu.au/clinical-trials/) or contact us using the details in the image. Our friendly team look forward to hearing from you. 😊

Team ATIC are looking forward to being at the IDF-WPR/ADC 2026 combined congress next week in Melbourne.  We will be exh...
13/08/2026

Team ATIC are looking forward to being at the IDF-WPR/ADC 2026 combined congress next week in Melbourne. We will be exhibiting in the Breakthrough T1D Australia booth (booth 112) and we are looking forward to a week of learning, sharing and collaborating. We're excited to meet those of you that will be there too - please come and say hello!

The SAFEGUARD study is now available for 12-17 year olds in Australia and New Zealand!If you know a child or teen who ha...
07/08/2026

The SAFEGUARD study is now available for 12-17 year olds in Australia and New Zealand!
If you know a child or teen who has been diagnosed with type 1 diabetes in the last 100 days, they might be interested in being involved in a clinical trial of a new medicine that is hoped to protect the body's ability to make insulin, please visit our website for more information or to register your interest at atic.svi.edu.au/clinical-trials

Reminder!  Prof Simon Barry will be presenting the Beyond Insulin seminar tomorrow.  Registration details are in the pos...
30/07/2026

Reminder! Prof Simon Barry will be presenting the Beyond Insulin seminar tomorrow. Registration details are in the post below. Look forward to seeing you there.

Seminar 33, Beyond Insulin Seminar Series - Professor Simon Barry presents Using Immunogenomics to unravel the drivers of progression in T1D: the path to prevention and cure?

The MT101-101 study is now available in Victoria and Queensland.  If you are an adult with type 1 diabetes and you are i...
27/07/2026

The MT101-101 study is now available in Victoria and Queensland. If you are an adult with type 1 diabetes and you are interested in taking part in research for a new therapy, please visit our website (atic.svi.edu.au/clinical-trials/) or contact us using the details in the image.

What an inspiring day at the   Type 1 Summit!ATIC was proud to be part of this year's event, connecting with the type 1 ...
27/07/2026

What an inspiring day at the Type 1 Summit!
ATIC was proud to be part of this year's event, connecting with the type 1 diabetes community and sharing the latest developments in research aimed at changing the future of the condition. Thank you to Breakthrough T1D Australia for inviting us to contribute to the research session on the main stage.
Professor Jenny Couper highlighted the growing role of type 1 diabetes screening, the stages of the condition, and the development of therapies that can delay the onset of clinical type 1 diabetes. ATIC Community Engagement Lead Meaghan Read then shared her perspective as someone who has lived with type 1 diabetes for almost 40 years, speaking about the vital role of lived expertise in shaping research and encouraging the community to partner with researchers to drive meaningful progress.
One of the greatest parts of events like this is the opportunity to connect with people living with type 1 diabetes and their loved ones. Thank you to everyone who stopped by to share your experiences, ask questions and learn more about the exciting research taking place across Australia.
These conversations remind us why we do what we do. Together, through research, collaboration and community partnership, we're working towards a future where we can delay, prevent and hopefully cure type 1 diabetes.

Candice and Meaghan are excited to be in Adelaide for Breakthrough T1D Australia Type 1 Summit. We’d love to meet you if...
25/07/2026

Candice and Meaghan are excited to be in Adelaide for Breakthrough T1D Australia Type 1 Summit. We’d love to meet you if you are here!

Address

9 Princes Street
Fitzroy, VIC
3065

Opening Hours

Monday 8:30am - 4pm
Tuesday 8:30am - 4pm
Wednesday 8:30am - 4pm
Thursday 8:30am - 4pm
Friday 8:30am - 4pm

Telephone

+61392312480

Alerts

Be the first to know and let us send you an email when ATIC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ATIC:

Shortcuts

Share